These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1254956)

  • 21. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
    Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral and cell-mediated immune response to influenza virus. I. Experiments in mice.
    Semkow R; Loza-Tulimowska M; Wilczyński J; Brydak L; Zgorzelska K
    Acta Microbiol Pol; 1982; 31(2):185-94. PubMed ID: 6188341
    [No Abstract]   [Full Text] [Related]  

  • 24. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.
    Scherle PA; Palladino G; Gerhard W
    J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of serum antibody responses to influenza virus antigens.
    Couch RB
    Dev Biol (Basel); 2003; 115():25-30. PubMed ID: 15088772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses.
    Bot A; Holz A; Christen U; Wolfe T; Temann A; Flavell R; von Herrath M
    Virology; 2000 Mar; 269(1):66-77. PubMed ID: 10725199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain.
    Sidorova LA; Alekseyeva AK
    Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209
    [No Abstract]   [Full Text] [Related]  

  • 29. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
    Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR
    Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initiation of antibody responses by different classes of lymphocytes. IV. Lymphocytes involved in the primary antibody response to a hapten-protein conjugate.
    Strober S; Law LW
    Immunology; 1971 May; 20(5):831-8. PubMed ID: 4137730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice.
    Hovden AO; Cox RJ; Madhun A; Haaheim LR
    Scand J Immunol; 2005 Oct; 62(4):342-52. PubMed ID: 16253121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
    Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
    Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of preinfection and preimmunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines.
    Jennings R; Potter CW; McLaren C
    J Immunol; 1974 Dec; 113(6):1834-43. PubMed ID: 4547776
    [No Abstract]   [Full Text] [Related]  

  • 36. Humoral immunity in aged mice. I. Age-related decline in the secondary response to DNP of spleen cells propagated in diffusion chambers.
    Segre M; Segre D
    J Immunol; 1976 Mar; 116(3):731-4. PubMed ID: 768374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination and protection experiments in mice with the human A-1957 and A-1968 strains, and the Equi-2 strain of influenza virus.
    Masurel N; Baars AJ; Frankena H
    Antonie Van Leeuwenhoek; 1973; 39(3):461-71. PubMed ID: 4543055
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of influenza virus hemagglutinin, neuraminidase and their antibody responses in infected patients.
    Chen SH; Huang CH; Yang YJ; Hsia S
    Taiwan Yi Xue Hui Za Zhi; 1973 Jun; 72(6):319-24. PubMed ID: 4519978
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the in vitro formation of antibodies. III. Induction of primary and secondary immune response in vitro].
    Schiek W
    Z Immunitatsforsch Exp Klin Immunol; 1975 May; 148(5):431-50. PubMed ID: 127451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The autoimmune response to male reproductive tissues of rabbits. IV. Induction of autosensitization to central accessory tissue by the intraabdominal release of endogenous secretions.
    Barnes GW; Stoll HW; Barnes MS; Tiwari AD
    Invest Urol; 1976 Jul; 14(1):47-53. PubMed ID: 955849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.